- Home
- LNTH vs MIAX Comparison
LNTH vs MIAX Comparison
Compare LNTH & MIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | MIAX |
|---|---|---|
| Founded | 1956 | 2007 |
| Country | United States | United States |
| Employees | N/A | 439 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 3.5B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | MIAX |
|---|---|---|
| Price | $79.49 | $38.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $83.20 | $48.00 |
| AVG Volume (30 Days) | 1.0M | ★ 1.6M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.41 | N/A |
| Revenue | ★ $343,374,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.47 | $12.06 |
| P/E Ratio | $23.56 | ★ N/A |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $47.27 | $31.20 |
| 52 Week High | $108.86 | $51.38 |
Technical Indicators
Market Signals| Indicator | LNTH | MIAX |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 36.89 |
| Support Level | $77.38 | $34.02 |
| Resistance Level | $83.53 | $38.44 |
| Average True Range (ATR) | 3.71 | 1.73 |
| MACD | 0.28 | -0.31 |
| Stochastic Oscillator | 60.42 | 10.93 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About MIAX Miami International Holdings Inc.
Miami International Holdings Inc is engaged in operating regulated financial marketplaces across multiple asset classes using proprietary technology platforms. The company operates exchange markets for options, equities, futures, and international listings through its MIAX Exchanges, MIAX Futures Exchange, and the Bermuda Stock Exchange. The company operates through four reportable segments: Options, which provides trading and market data services for listed equity and ETP options; Equities, which provides trading services for U.S. equities and ETPs; Futures, which provides futures trading and clearing services through MIAX Futures; and International, which provides listing services for capital market instruments through the Bermuda Stock Exchange and The International Stock Exchange.